Genetic and transcriptional evolution alters cancer cell line drug responseUri Ben‐David, Todd R. Golub, Benjamin A. Siranosian et al.|Nature|2018Cited by 943
The tumorigenicity of human embryonic and induced pluripotent stem cellsUri Ben‐David, Nissim Benvenisty|Nature reviews. Cancer|2011Cited by 886
Discovering the anticancer potential of non-oncology drugs by systematic viability profilingSteven M. Corsello, Todd R. Golub, Li Wang et al.|Nature Cancer|2020Cited by 880
Identification and Classification of Chromosomal Aberrations in Human Induced Pluripotent Stem CellsYoav Mayshar, Nissim Benvenisty, Uri Ben‐David et al.|Cell stem cell|2010Cited by 768
Context is everything: aneuploidy in cancerUri Ben‐David, Angelika Amon|Nature Reviews Genetics|2019Cited by 736